首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents
【24h】

Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents

机译:基于结构的杂交,合成和生物评价新型四环杂环硫杂蒽酮类似物作为潜在的抗肿瘤药

获取原文
获取原文并翻译 | 示例
           

摘要

A series of tetracyclic heterocyclic azathioxanthones were synthesized and evaluated for cell proliferations, topoisomerase inhibitions, and NCI-60 cell panel assay, respectively. Compounds 5, 7, 8, 16, and 19 were selected for topoisomerase assay after MTT assay. 7 not only showed cytotoxic effect (IC50 2.84 +/- 0.64 mu M) in PC-3 cells but also revealed topoisomerases inhibition with IC50 (10-25 mu M) and increased apoptotic cleavage of PARP and caspase 3 activity. The overall of novel azathioxanthones with different cytostatic and cytotoxic activities should be further developed as new potential candidates for anticancer drugs. (C) 2015 Elsevier Masson SAS. All rights reserved.
机译:合成了一系列四环杂环硫唑嘌呤类化合物,并分别评估了细胞增殖,拓扑异构酶抑制作用和NCI-60细胞检测。在MTT测定后,选择化合物5、7、8、16和19进行拓扑异构酶测定。 7不仅在PC-3细胞中显示出细胞毒性作用(IC50 2.84 +/- 0.64μM),而且还显示了IC50(10-25μM)对拓扑异构酶的抑制作用,并增加了PARP的凋亡裂解和caspase 3活性。具有不同细胞抑制活性和细胞毒性活性的新型硫唑嘌呤类化合物的整体应进一步开发,作为抗癌药物的潜在新候选者。 (C)2015 Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号